XML 13 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Series A Convertible Preferred Stock
Series B Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Convertible Preferred Stock, beginning balance at Dec. 31, 2023   $ 89,487 $ 77,091        
Convertible Preferred Stock, beginning balance, shares at Dec. 31, 2023   100,182,354 51,273,790        
Beginning balance at Dec. 31, 2023 $ (25,634)     $ 4 $ 19,796 $ 4 $ (45,438)
Beginning balance, shares at Dec. 31, 2023       4,170,817      
Issuance of Series B convertible preferred stock for the settlement of the tranche right liability, net of issuance costs 7,343   $ 68,161   7,343    
Issuance of Series B convertible preferred stock for the settlement of the tranche right liability, net of issuance costs, shares     38,157,240        
Stock-based compensation expense 1,491       1,491    
Net loss (22,669)           (22,669)
Change in unrealized gain (loss) on investments, net of tax (164)         (164)  
Convertible Preferred Stock, ending balance at Mar. 31, 2024 $ 234,739 $ 89,487 $ 145,252        
Convertible Preferred Stock, ending balance, shares at Mar. 31, 2024 189,613,384 100,182,354 89,431,030        
Ending balance at Mar. 31, 2024 $ (39,633)     $ 4 28,630 (160) (68,107)
Ending balance, shares at Mar. 31, 2024       4,170,817      
Convertible Preferred Stock, beginning balance at Dec. 31, 2023   $ 89,487 $ 77,091        
Convertible Preferred Stock, beginning balance, shares at Dec. 31, 2023   100,182,354 51,273,790        
Beginning balance at Dec. 31, 2023 (25,634)     $ 4 19,796 4 (45,438)
Beginning balance, shares at Dec. 31, 2023       4,170,817      
Net loss (78,300)            
Ending balance at Dec. 31, 2024 $ 305,427     $ 37 429,657 (522) (123,745)
Ending balance, shares at Dec. 31, 2024 36,580,202     36,580,202      
Stock-based compensation expense $ 4,040       4,040    
Issuance of common stock upon exercise of stock options $ 6       6    
Issuance of common stock upon exercise of stock options, shares 3,240     3,240      
Repurchase of unvested restricted common stock $ (1)       (1)    
Repurchase of unvested restricted common stock, shares       (86,008)      
Net loss (24,063)           (24,063)
Change in unrealized gain (loss) on investments, net of tax 427         427  
Ending balance at Mar. 31, 2025 $ 285,836     $ 37 $ 433,702 $ (95) $ (147,808)
Ending balance, shares at Mar. 31, 2025 36,497,434     36,497,434